APA
Rodríguez-Cid J. R., Campos-Gomez S., García-Montes V., Magallanes-Maciel M., Flores-Mariñelarena R. R., Fernández-Garibay V. M., González-Espinoza I. R., Ceja-García J. P., Cázarez-Price J. C., Martínez-Barrera L., Barriguete-Parra L., Zuloaga-Fernandez C. J., Kuri-Exsome R., Suárez-García D., Gonzalez-Villanueva J. I., Flores-Anaya N., Acevedo-Delgado J. A., Astorga-Ramos A. M., Gerson-Cwilich R., Villalobos-Prieto A., Rodríguez-Silva C., Noriega-Iriondo M. F., Vázquez-Cortés L., Perales-Rodríguez E., Acosta-Espinoza A., Perez-Lozano Y., Capdeville-García D. & Alatorre-Alexander J. A. (20210728). Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma. : JCO global oncology.
Chicago
Rodríguez-Cid Jeronimo Rafael, Campos-Gomez Saul, García-Montes Vanessa, Magallanes-Maciel Manuel, Flores-Mariñelarena Rodrigo Rafael, Fernández-Garibay Valeria Michelle, González-Espinoza Iván Romarico, Ceja-García Juan Paulo, Cázarez-Price Juan Carlos, Martínez-Barrera Luis, Barriguete-Parra Leopoldo, Zuloaga-Fernandez Carlos Jose, Kuri-Exsome Roberto, Suárez-García David, Gonzalez-Villanueva Jorge Ignacio, Flores-Anaya Noé, Acevedo-Delgado Jose Antonio, Astorga-Ramos Alma Magdalena, Gerson-Cwilich Raquel, Villalobos-Prieto Alberto, Rodríguez-Silva Claudia, Noriega-Iriondo Maria Fernanda, Vázquez-Cortés Leticia, Perales-Rodríguez Eusebio, Acosta-Espinoza Alicia, Perez-Lozano Yareni, Capdeville-García Daniel and Alatorre-Alexander Jorge Arturo. 20210728. Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma. : JCO global oncology.
Harvard
Rodríguez-Cid J. R., Campos-Gomez S., García-Montes V., Magallanes-Maciel M., Flores-Mariñelarena R. R., Fernández-Garibay V. M., González-Espinoza I. R., Ceja-García J. P., Cázarez-Price J. C., Martínez-Barrera L., Barriguete-Parra L., Zuloaga-Fernandez C. J., Kuri-Exsome R., Suárez-García D., Gonzalez-Villanueva J. I., Flores-Anaya N., Acevedo-Delgado J. A., Astorga-Ramos A. M., Gerson-Cwilich R., Villalobos-Prieto A., Rodríguez-Silva C., Noriega-Iriondo M. F., Vázquez-Cortés L., Perales-Rodríguez E., Acosta-Espinoza A., Perez-Lozano Y., Capdeville-García D. and Alatorre-Alexander J. A. (20210728). Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma. : JCO global oncology.
MLA
Rodríguez-Cid Jeronimo Rafael, Campos-Gomez Saul, García-Montes Vanessa, Magallanes-Maciel Manuel, Flores-Mariñelarena Rodrigo Rafael, Fernández-Garibay Valeria Michelle, González-Espinoza Iván Romarico, Ceja-García Juan Paulo, Cázarez-Price Juan Carlos, Martínez-Barrera Luis, Barriguete-Parra Leopoldo, Zuloaga-Fernandez Carlos Jose, Kuri-Exsome Roberto, Suárez-García David, Gonzalez-Villanueva Jorge Ignacio, Flores-Anaya Noé, Acevedo-Delgado Jose Antonio, Astorga-Ramos Alma Magdalena, Gerson-Cwilich Raquel, Villalobos-Prieto Alberto, Rodríguez-Silva Claudia, Noriega-Iriondo Maria Fernanda, Vázquez-Cortés Leticia, Perales-Rodríguez Eusebio, Acosta-Espinoza Alicia, Perez-Lozano Yareni, Capdeville-García Daniel and Alatorre-Alexander Jorge Arturo. Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma. : JCO global oncology. 20210728.